Back
Protalix BioTherapeutics Stock Price Chart
Sponsored
PLX
Sponsored
My #1 Coin is...
All the details are on the next page.
Sell
36
PLX
Protalix BioTherapeutics
Last Price:
1.15
Seasonality Move:
0.76%
7 Day Trial
ALL ACCESS PASS
$
7
This DeFi Coin Could 10x Soon... I Advise You Get In Now!
Discover this DeFi diamond before the next surge- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLX is experiencing selling pressure, which indicates risk of future bearish movement.
Protalix BioTherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.17 | Sell |
20-day SMA: | 1.19 | Sell |
50-day SMA: | 1.3 | Sell |
200-day SMA: | 1.55 | Sell |
8-day EMA: | 1.17 | Sell |
20-day EMA: | 1.19 | Sell |
50-day EMA: | 1.28 | Sell |
200-day EMA: | 1.51 | Sell |
Protalix BioTherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 42.28 | Sell |
Chaikin Money Flow: | -147291 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.14 - 1.24) | Sell |
Bollinger Bands (100): | (1.25 - 1.65) | Sell |
Protalix BioTherapeutics Technical Analysis
Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.14 while PLX 8-day simple moving average is 1.17, which is a Sell signal.
- The stock price of PLX is 1.14 while Protalix BioTherapeutics 20-day SMA is 1.19, which makes it a Sell.
- Protalix BioTherapeutics 50-day simple moving average is 1.30 while PLX share price is 1.14, making it a Sell technically.
- PLX stock price is 1.14 and Protalix BioTherapeutics 200-day simple moving average is 1.55, creating a Sell signal.
PLX Technical Analysis vs Fundamental Analysis
Sell
36
Protalix BioTherapeutics (PLX)
is a Sell
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a Sell
The current Protalix BioTherapeutics [PLX] share price is $1.14. The Score for PLX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
83.28M
Price in USD:
1.14
Share Volume:
231.46K
Protalix BioTherapeutics 52-Week Range
52-Week High:
3.55
52-Week Low:
1.09
Sell
36
Protalix BioTherapeutics (PLX)
is a Sell
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?
The Protalix BioTherapeutics stock price is 1.14 USD today. -
Will PLX stock go up or go down?
Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Protalix BioTherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is overvalued.
Is Protalix BioTherapeutics Stock a Buy?
- Protalix BioTherapeutics share price is 1.14 while PLX 8-day exponential moving average is 1.17, which is a Sell signal.
- The stock price of PLX is 1.14 while Protalix BioTherapeutics 20-day EMA is 1.19, which makes it a Sell.
- Protalix BioTherapeutics 50-day exponential moving average is 1.28 while PLX share price is 1.14, making it a Sell technically.
- PLX stock price is 1.14 and Protalix BioTherapeutics 200-day simple moving average is 1.51, creating a Sell signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
- PLX Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Protalix BioTherapeutics is a Sell
- Protalix BioTherapeutics Relative Strength Index (RSI) is 42.28, which suggest Protalix BioTherapeutics is oversold
- The Bollinger Bands (25) for Protalix BioTherapeutics is (1.14 - 1.24), which suggest Protalix BioTherapeutics is a Sell
- The Bollinger Bands (100) for Protalix BioTherapeutics is (1.25 - 1.65), which suggest Protalix BioTherapeutics is a Sell
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.